Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pell Bio-Med Technology Co. Ltd. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners, with each examiner handling 1 case. Both matters are situated within 1 distinct art unit, which suggests a tight technical focus for the company's current biotechnology research. This concentration in 1 distinct art unit may allow for more predictable prosecution within that specific group.
CONIGLIO, AUDREA JUNE BUCKLEY is identified as the busiest examiner with 1 pending office action. Since there are 2 pending office actions in total, the workload is shared between the 2 distinct examiners. The concentration within 1 distinct art unit suggests a unified technical focus despite the involvement of 2 distinct examiners. Practitioners should monitor the 2 pending office actions for any common prior art or technical rejections that might arise within this 1 art unit.
With 2 pending office actions and 2 distinct examiners, the company must address 2 different individual perspectives. CONIGLIO, AUDREA JUNE BUCKLEY handles 1 pending office action, making her responsible for a portion of the active portfolio. Because both cases are in 1 distinct art unit, the company may benefit from the shared expertise of the examiners in that field. This balance of 2 distinct examiners within 1 art unit provides a focused yet diverse review of the company's pharmaceutical innovations.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 52.9% | +21.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18944316 | COMPOSITION FOR PROMOTING HAIR GROWTH, PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH COMPRISING THE COMPOSITION, AND METHOD FOR PROMOTING HAIR GROWTH BY USING THE SAME | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18944316 | COMPOSITION FOR PROMOTING HAIR GROWTH, PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH COMPRISING THE COMPOSITION, AND METHOD FOR PROMOTING HAIR GROWTH BY USING THE SAME | CONIGLIO, AUDREA JUNE BUCKLEY | — | §103 | Non-Final OA | — | Pending | Nov 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial